Aria Pharmaceuticals (Series A+)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $90,000,000
Company Info
- Founders
- Andrew Radin
- Company Description
- A preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases; the company's refined drug discovery approach purportedly saves as much as 3 years in drug development and increases success rates 30X vs. traditional methods. Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.
- Market
- Healthcare & Wellness
- Coinvestors
- OS Fund,SoftBank,Andreessen Horowitz